|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1202052331 |
003 |
OCoLC |
005 |
20231120010515.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
201028t20212021enk of 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d OPELS
|d OCLCF
|d OCLCO
|d INM
|d OCLCO
|d USU
|d OCLCA
|d VRC
|d N$T
|d OPELS
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d K6U
|d OCL
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780128193686
|q (electronic bk.)
|
020 |
|
|
|a 0128193689
|q (electronic bk.)
|
020 |
|
|
|z 9780128193679
|
020 |
|
|
|z 0128193670
|
035 |
|
|
|a (OCoLC)1202052331
|
050 |
|
4 |
|a RD598.35.C35
|
060 |
|
4 |
|a WG 141.5.C2
|
082 |
0 |
4 |
|a 616.1/20754
|2 23
|
100 |
1 |
|
|a Brilakis, Emmanouil S.,
|e editor.
|
245 |
1 |
0 |
|a Manual of percutaneous coronary interventions :
|b a step-by-step approach /
|c Emmanouil Brilakis.
|
264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c [2021]
|
264 |
|
4 |
|c �2021
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover -- Manual of Percutaneous Coronary Interventions -- Copyright Page -- Dedication -- Contents -- List of contributors -- PCI cases online links -- CTO PCI cases online links -- Introduction -- Reference -- A. The steps -- 1 Planning -- 1.1 Planning -- 1.2 Monitoring -- 1.3 Pharmacology -- 1.4 Access -- 1.5 Engagement -- 1.6 Angiography -- 1.7 Determine target lesion(s) -- 1.8 Wiring -- 1.9 Lesion preparation -- 1.10 Stenting -- 1.11 Access closure -- 1.12 Physiology -- 1.13 Imaging -- 1.14 Hemodynamic support -- References -- 2 Monitoring -- 2.1 Patient -- 2.2 Electrocardiogram
|
505 |
8 |
|
|a 2.3. Pressure waveform -- 2.4 Oxygen saturation -- 2.5 Radiation dose-X-ray system and shield positioning -- 2.6 Contrast volume -- 2.7 Access site -- 2.8 Medication administration (anticoagulation-ACT, sedation, other medications) -- 2.9 Operator and t3 eam performance -- 2.10 Cath lab environment -- 2.11 Sterile field and equipment -- 2.12 Equipment position within the body -- 3 Medications -- 3.1 Sedatives and analgesics -- 3.1.1 Goals -- 3.1.2 How? -- 3.1.3 What can go wrong? -- 3.1.3.1 Respiratory failure-hypopnea
|
505 |
8 |
|
|a 3.1.3.2 Delayed response to oral P2Y12 inhibitors which may lead to thrombotic complications -- 3.2 Vasodilators -- 3.2.1 Nitroglycerin -- 3.2.1.1 Goals -- 3.2.1.2 How? -- 3.2.1.3 What can go wrong? -- 3.2.1.3.1 Hypotension -- 3.2.1.3.2 Headache, flushing, dizziness -- 3.2.1.3.3 Tachycardia -- 3.2.2 Nicardipine -- 3.2.2.1 Goals -- 3.2.2.2 How? -- 3.2.2.3 What can go wrong? -- 3.2.2.3.1 Hypotension -- 3.2.3 Nitroprusside -- 3.2.3.1 Goals -- 3.2.3.2 How? -- 3.2.3.3 What can go wrong? -- 3.2.3.3.1 Hypotension -- 3.2.4 Verapamil -- 3.2.4.1 Goals -- 3.2.4.2 How? -- 3.2.4.3 What can go wrong?
|
505 |
8 |
|
|a 3.2.4.3.1 Hypotension -- 3.2.5 Adenosine -- 3.2.5.1 Goals -- 3.2.5.2 How? -- 3.2.5.3 What can go wrong? -- 3.2.5.3.1 Heart block -- 3.2.5.3.2 Atrial fibrillation -- 3.2.5.3.3 Ventricular fibrillation -- 3.3 Contrast media -- 3.3.1 Goals -- 3.3.2 How? -- 3.3.3 What can go wrong? -- 3.3.3.1 Contrast-induced acute kidney injury -- 3.3.3.2 Allergic reactions -- 3.3.3.3 Thyroid dysfunction -- 3.4 Anticoagulants -- 3.4.1 Goals -- 3.4.2 How? -- 3.4.2.1 Unfractionated heparin -- 3.4.2.1.1 Dose -- 3.4.2.1.2 Monitoring -- 3.4.2.1.3 Reversal -- 3.4.2.2 Bivalirudin -- 3.4.2.2.1 Dose -- 3.4.2.2.2 Monitoring
|
505 |
8 |
|
|a 3.4.2.2.3 Reversal -- 3.4.3 Challenges -- 3.4.3.1 ACT is low after anticoagulant administration -- 3.4.4 What can go wrong? -- 3.4.4.1 Bleeding -- 3.4.4.2 Thrombosis -- 3.4.4.3 Heparin-induced thrombocytopenia (HIT) -- 3.5 Antiplatelet agents -- 3.5.1 Dual antiplatelet therapy -- 3.5.1.1 Goals -- 3.5.1.2 How? -- 3.5.1.2.1 Medication type -- 3.5.1.2.2 Dose -- 3.5.1.2.3 Pretreatment -- 3.5.1.2.4 Switching between oral P2Y12 inhibitors -- 3.5.1.2.5 DAPT duration -- 3.5.1.3 What can go wrong? -- 3.5.1.3.1 Bleeding -- 3.5.1.3.2 Dyspnea -- 3.5.1.3.3 Allergic reactions
|
650 |
|
0 |
|a Cardiac catheterization.
|
650 |
|
0 |
|a Heart
|x Surgery.
|
650 |
|
0 |
|a Heart
|x Diseases
|x Treatment.
|
650 |
1 |
2 |
|a Angioplasty
|x methods
|0 (DNLM)D017130Q000379
|
650 |
|
2 |
|a Cardiac Catheterization
|0 (DNLM)D006328
|
650 |
|
2 |
|a Thoracic Surgery
|0 (DNLM)D013903
|
650 |
|
2 |
|a Heart Diseases
|x therapy
|0 (DNLM)D006331Q000628
|
650 |
2 |
2 |
|a Cardiovascular Diseases
|x surgery
|0 (DNLM)D002318Q000601
|
650 |
2 |
2 |
|a Coronary Artery Disease
|x surgery
|0 (DNLM)D003324Q000601
|
650 |
|
6 |
|a Cath�et�erisme cardiaque.
|0 (CaQQLa)201-0084316
|
650 |
|
6 |
|a C�ur
|x Chirurgie.
|0 (CaQQLa)201-0017090
|
650 |
|
6 |
|a C�ur
|x Maladies
|x Traitement.
|0 (CaQQLa)201-0210152
|
650 |
|
7 |
|a Cardiac catheterization
|2 fast
|0 (OCoLC)fst00847050
|
650 |
|
7 |
|a Heart
|x Diseases
|x Treatment
|2 fast
|0 (OCoLC)fst00953569
|
650 |
|
7 |
|a Heart
|x Surgery
|2 fast
|0 (OCoLC)fst00953666
|
655 |
|
2 |
|a Handbook
|0 (DNLM)D020479
|
655 |
|
7 |
|a handbooks.
|2 aat
|0 (CStmoGRI)aatgf300311807
|
655 |
|
7 |
|a Handbooks and manuals
|2 fast
|0 (OCoLC)fst01423877
|
655 |
|
7 |
|a Handbooks and manuals.
|2 lcgft
|
655 |
|
7 |
|a Guides et manuels.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001065
|
776 |
0 |
8 |
|i Print version:
|a Brilakis, Emmanouil S.
|t Manual of percutaneous coronary interventions.
|d London, United Kingdom ; San Diego, CA : Academic Press, [2021]
|z 9780128193679
|w (OCoLC)1130279690
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128193679
|z Texto completo
|